| Identification | Back Directory | [Name]
5-chloro-4-[(3,4-dichlorophenoxy)Methyl]-2-fluoro-N-(Methylsulfonyl)benzaMide | [CAS]
1355631-24-1 | [Synonyms]
Nav1.7 inhibitor
5-chloro-4-[(3,4-dichlorophenoxy)Methyl]-2-fluoro-N-(Methylsulfonyl)benzaMide
Benzamide, 5-chloro-4-[(3,4-dichlorophenoxy)methyl]-2-fluoro-N-(methylsulfonyl)- | [Molecular Formula]
C15H11Cl3FNO4S | [MOL File]
1355631-24-1.mol | [Molecular Weight]
426.67 |
| Chemical Properties | Back Directory | [density ]
1.548±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Powder | [pka]
2.52±0.40(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Nav1.7 inhibitor (compound II), a sulfonamide, is a potent Nav1.7 inhibitor. Nav1.7 inhibitor has the potential for a wide range of disorders, particularly pain[1]. | [IC 50]
Nav1.7 | [storage]
Store at -20°C | [References]
[1] Alan Daniel Brown, et al. Preparation of sulfonamide derivatives as Nav1.7 inhibitors. Patent WO2012007868A2. |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
| Company Name: |
Musechem
|
| Tel: |
+1-800-259-7612 |
| Website: |
www.musechem.com |
|